SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034974
Filing Date
2024-03-22
Accepted
2024-03-21 20:51:47
Documents
94
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tsbx-20231231.htm   iXBRL 10-K 3367523
2 EX-4.3 tsbx-ex4_3.htm EX-4.3 36013
3 EX-23.1 tsbx-ex23_1.htm EX-23.1 2939
4 EX-31.1 tsbx-ex31_1.htm EX-31.1 12084
5 EX-31.2 tsbx-ex31_2.htm EX-31.2 12278
6 EX-32.1 tsbx-ex32_1.htm EX-32.1 8331
7 EX-97.1 tsbx-ex97_1.htm EX-97.1 40048
8 GRAPHIC img126556534_0.jpg GRAPHIC 1134573
9 GRAPHIC img126556534_1.jpg GRAPHIC 334020
10 GRAPHIC img126556534_2.jpg GRAPHIC 675179
11 GRAPHIC img126556534_3.jpg GRAPHIC 1134573
12 GRAPHIC img126556534_4.jpg GRAPHIC 329708
13 GRAPHIC img126556534_5.jpg GRAPHIC 269067
14 GRAPHIC img126556534_6.jpg GRAPHIC 331669
15 GRAPHIC img126556534_7.jpg GRAPHIC 334020
16 GRAPHIC img126556534_8.jpg GRAPHIC 446444
17 GRAPHIC img126556534_9.jpg GRAPHIC 538542
18 GRAPHIC img126556534_10.jpg GRAPHIC 769989
19 GRAPHIC img126556534_11.jpg GRAPHIC 811295
20 GRAPHIC img126556534_12.jpg GRAPHIC 430135
21 GRAPHIC img126556534_13.jpg GRAPHIC 1583217
22 GRAPHIC img126556534_14.jpg GRAPHIC 813618
23 GRAPHIC img126556534_15.jpg GRAPHIC 2175332
24 GRAPHIC img126556534_16.jpg GRAPHIC 334020
  Complete submission text file 0000950170-24-034974.txt   44791031

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20231231.xsd EX-101.SCH 1669141
98 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20231231_htm.xml XML 2043003
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41747 | Film No.: 24772863
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)